US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Products ETF

104.92

+2.922.86%

Post-market: 104.92-0.00150.00%16:00 EDT

Volume:25.82K

Turnover:2.71M

Market Cap:131.15M

PE:- -

High:105.65

Open:104.03

Low:103.98

Close:102.00

52wk High:110.05

52wk Low:68.05

Shares:1.25M

Float Shares:1.25M

Volume Ratio:2.78

T/O Rate:2.07%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Trex Acquisition Appoints Post Oak As M&A Advisor

AFT Pharmaceuticals Secures Tentative FDA Nod for Scomara, Eyes Growth Outside U.S.

Evofem Biosciences Updates Investors via New Presentation

3 Small-Cap ETFs With More Than 20% Upside, According to Wall Street

Amneal receives FDA approval for additional iohexol strengths, presentations

Arbutus Biopharma Reshapes Strategy After Moderna Settlement

Virax Biolabs Boosts Liquidity, Secures Fosun Deal and Restores Nasdaq Compliance After Fiscal 2026 Report

IMF warns Bank of England against cutting interest rates

Vanda announces EMA positive opinion for orphan drug designation of Imsidolimab

Attovia Therapeutics, a Biopharmaceutical Firm Focused on Immune-Mediated Diseases, Files for U.S. IPO Seeking $100 Million

Regeneron’s dupilumab granted orphan drug designation

Celcuity announces FDA approval of Revtorpyk

Caris Life Sciences expands prostate cancer offering with PTEN IHC testing

Nexalis Therapeutics Options Expire Unexercised, Streamlining Capital Structure

Nexalis Therapeutics Issues Over 4.1 Million Unquoted Performance Rights

BioArctic’s Partner Eisai Wins FDA Nod for At-Home Leqembi Injection in Early Alzheimer’s

Lakefront Biotherapeutics Board Member Resigns After Sanofi R&D Appointment

Actinogen Medical Announces Employee Share Scheme Buy-Back

Island Pharmaceuticals Issues Unquoted Options Under Employee Incentive Scheme

Insilico Medicine Surges Over 7% in Morning Trading on New AI Drug Discovery Partnership with CMS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/BBP/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Products ETF","latestPrice":104.92,"timestamp":1789675200000,"preClose":101.9998,"halted":0,"volume":25815,"hourTrading":{"tag":"盘后","latestPrice":104.9185,"preClose":104.92,"latestTime":"16:00 EDT","volume":2,"amount":209.837,"timestamp":1789675212195,"change":-0.0015,"changeRate":-0.000014,"amplitude":0},"delay":0,"changeRate":0.028629467900917537,"floatShares":1250004,"shares":1250004,"eps":0,"marketStatus":"Post-Mkt","change":2.9202,"latestTime":"09-17 16:02:51 EDT","open":104.03,"high":105.65,"low":103.975,"amount":2710408,"amplitude":0.016422,"askPrice":120.43,"askSize":100,"bidPrice":91.28,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789689600000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":101.9998,"sharesOutstanding":600004,"nav":101.285,"aum":121542550.39,"bidAskSpread":0.002402,"preHourTrading":{"tag":"盘前","latestPrice":101.9998,"preClose":101.9998,"latestTime":"07:00 EDT","volume":1,"amount":101.9998,"timestamp":1789642858616,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":104.9185,"preClose":104.92,"latestTime":"16:00 EDT","volume":2,"amount":209.837,"timestamp":1789675212195,"change":-0.0015,"changeRate":-0.000014,"amplitude":0},"volumeRatio":2.784489,"impliedVol":0.2249,"impliedVolPercentile":0.4343},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","floatShares":1250004,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.784489,"shares":1250004,"dividePrice":0,"high":105.65,"amplitude":0.016422,"preClose":101.9998,"low":103.975,"week52Low":68.046,"pbRate":"--","week52High":110.05,"institutionHeld":0,"latestPrice":104.92,"eps":0,"divideRate":0,"volume":25815,"delay":0,"ttmEps":0,"open":104.03,"prevYearClose":79.9149,"prevWeekClose":103.4597,"prevMonthClose":106.46,"prevQuarterClose":96.2686,"fiveDayClose":103.4736,"twentyDayClose":109.9037,"sixtyDayClose":92.7358},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBP\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBP\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2653862677","title":"Trex Acquisition Appoints Post Oak As M&A Advisor","url":"https://stock-news.laohu8.com/highlight/detail?id=2653862677","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653862677?lang=en_us&edition=fundamental","pubTime":"2026-07-22 05:48","pubTimestamp":1784670496,"startTime":"0","endTime":"0","summary":"Trex Acquisition ( ($TRXA) ) has provided an update. Trex Acquisition operates in the mergers and acquisitions space, focusing on corporate transac...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/trex-acquisition-appoints-post-oak-as-ma-advisor?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/trex-acquisition-appoints-post-oak-as-ma-advisor?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KI","POST","BK4544","TREX","BK4564","ZIG","BK4086","ARKX","GABF","GTPE","PEX","UFO","BBP","PEVC","LRCY","KCE","BK4212"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653529241","title":"AFT Pharmaceuticals Secures Tentative FDA Nod for Scomara, Eyes Growth Outside U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2653529241","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653529241?lang=en_us&edition=fundamental","pubTime":"2026-07-21 06:47","pubTimestamp":1784587635,"startTime":"0","endTime":"0","summary":"An announcement from AFT Pharmaceuticals Ltd. ( ($NZ:AFT) ) is now available. AFT Pharmaceuticals has received tentative U.S. FDA approval for Scom...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aft-pharmaceuticals-secures-tentative-fda-nod-for-scomara-eyes-growth-outside-u-s?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aft-pharmaceuticals-secures-tentative-fda-nod-for-scomara-eyes-growth-outside-u-s?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IYH","GDOC","BMED","LABU","TECB","PINK","PSCH","IDNA","MRNY","BK4585","IBB","SYNB","MRNX","RSPH","BK4588","LFSC","FRTY","AFT","MEDI","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653624696","title":"Evofem Biosciences Updates Investors via New Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2653624696","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653624696?lang=en_us&edition=fundamental","pubTime":"2026-07-21 04:52","pubTimestamp":1784580764,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Evofem Biosciences ( ($EVFM) ). Evofem Biosciences, Inc., a biotechnology company focused on women’s health, pe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/evofem-biosciences-updates-investors-via-new-presentation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/evofem-biosciences-updates-investors-via-new-presentation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4211","DARP","IBB","SYNB","FHLC","JDOC","AGNG","XT","ISBC","FWD","RSPH","BK4585","BK4588","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652443281","title":"3 Small-Cap ETFs With More Than 20% Upside, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2652443281","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652443281?lang=en_us&edition=fundamental","pubTime":"2026-07-17 23:06","pubTimestamp":1784300760,"startTime":"0","endTime":"0","summary":"Small-cap stocks have lagged large-cap peers in recent years as higher interest rates and slowing economic growth favored larger, more established ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/3-small-cap-etfs-with-more-than-20-upside-according-to-wall-street?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/3-small-cap-etfs-with-more-than-20-upside-according-to-wall-street?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CAOS","07366","TSL","TSII","JPAN","ANEW","AVSD","CLIX","TSLP","TSLO","09366","IMCG","TSLL","PEVC","CRSH","DFUV","TSLG","TSLW","TSLT","VAW","CGDV","TESL","TLA","TSLS","IJK","TSDD","DFND","FXL","UCC","09766","PEX","FXR","TSLY","TSLI","KOMP","BK4588","BK4585","BBP","TSLZ","QOWZ","TEST","TSLQ","07766","TSYY","TSLR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652882192","title":"Amneal receives FDA approval for additional iohexol strengths, presentations","url":"https://stock-news.laohu8.com/highlight/detail?id=2652882192","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652882192?lang=en_us&edition=fundamental","pubTime":"2026-07-17 20:15","pubTimestamp":1784290509,"startTime":"0","endTime":"0","summary":"Amneal Pharmaceuticals (AMRX) announced that it has received FDA approval for additional strengths and vial presentations of iohexol injection, 350...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amneal-receives-fda-approval-for-additional-iohexol-strengths-presentations-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amneal-receives-fda-approval-for-additional-iohexol-strengths-presentations-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FRTY","MRNX","AMRX","PINK","BK4585","TECB","IYH","PSCH","BK4588","SYNB","BBP","BK4007","LABU","MEDI","RSPH","GDOC","MRNY","IBB","IDNA","BMED","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652184401","title":"Arbutus Biopharma Reshapes Strategy After Moderna Settlement","url":"https://stock-news.laohu8.com/highlight/detail?id=2652184401","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652184401?lang=en_us&edition=fundamental","pubTime":"2026-07-17 17:37","pubTimestamp":1784281058,"startTime":"0","endTime":"0","summary":"Arbutus Biopharma ( ($ABUS) ) has provided an announcement. In March 2026, Arbutus, Genevant and Moderna entered a global patent litigation settlem...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/arbutus-biopharma-reshapes-strategy-after-moderna-settlement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/arbutus-biopharma-reshapes-strategy-after-moderna-settlement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABUS","BBP","BK4139","RND","NXTI","USRD","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652409835","title":"Virax Biolabs Boosts Liquidity, Secures Fosun Deal and Restores Nasdaq Compliance After Fiscal 2026 Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2652409835","media":"TIPRANKS","labels":["corporation","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652409835?lang=en_us&edition=fundamental","pubTime":"2026-07-17 16:48","pubTimestamp":1784278109,"startTime":"0","endTime":"0","summary":"Virax Biolabs Group Ltd. Class A ( ($VRAX) ) has issued an announcement. Virax Biolabs Group Limited, a Nasdaq-listed biotechnology company focused...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/virax-biolabs-boosts-liquidity-secures-fosun-deal-and-restores-nasdaq-compliance-after-fiscal-2026-report?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/virax-biolabs-boosts-liquidity-secures-fosun-deal-and-restores-nasdaq-compliance-after-fiscal-2026-report?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BBP","IBB","LCLG","RSPH","SYNB","NQmain","XT","BK4585","FHLC","DARP","FWD","AGNG","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652471130","title":"IMF warns Bank of England against cutting interest rates","url":"https://stock-news.laohu8.com/highlight/detail?id=2652471130","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652471130?lang=en_us&edition=fundamental","pubTime":"2026-07-17 11:55","pubTimestamp":1784260500,"startTime":"0","endTime":"0","summary":"The IMF said rates should remain on hold because of \"heightened uncertainty\"  The Bank of England must keep interest rates on hold for as long as risks from the Iran war persist, the International Monetary Fund has said.In its annual temperature check of Britain’s economic outlook, the fund warned rate setters to keep monetary policy “sufficiently restrictive” to avoid sparking a painful bout of inflation that becomes hard to contain.Economists have been closely monitoring the UK economy for signs that elevated oil prices caused by the Middle East conflict have led to a cascade of price rises in the wider economy.Bank of England policymakers are especially concerned about the emergence of so-called second-round effects – when an initial price shock spreads through an economy, leading workers to bargain for more wages, which in turn also gives companies breathing room to raise price further.","market":"nz","thumbnail":"https://www.cityam.com/wp-content/uploads/2026/07/IMF-boss-Kristalina-Georgieva-warned-the-Bank-of-England.jpg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2026/07/IMF-boss-Kristalina-Georgieva-warned-the-Bank-of-England.jpg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/imf-warns-bank-of-england-against-interest-rate/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/imf-warns-bank-of-england-against-interest-rate/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["TLA","TSLQ","FXL","TSL","ANEW","TSDD","TESL","TSLR","BBEU","CAOS","09766","TSII","TSLW","TSYY","BBP","KOMP","CGDV","BK4585","TEST","CLIX","TSLY","TSLZ","AVSD","CRSH","TSLG","IJK","07766","TSLO","09366","DFUV","VAW","ISVL","07366","BK4588","FXR","TSLS","PEVC","IDEV","TSLP","TSLL","FLGB","BK4582","TSLI","UCC","TSLT","IMF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652422420","title":"Vanda announces EMA positive opinion for orphan drug designation of Imsidolimab","url":"https://stock-news.laohu8.com/highlight/detail?id=2652422420","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652422420?lang=en_us&edition=fundamental","pubTime":"2026-07-17 04:35","pubTimestamp":1784234123,"startTime":"0","endTime":"0","summary":"Vanda Pharmaceuticals (VNDA) announced that the Committee for Orphan Medicinal Products at the European Medicines Agency has adopted a positive opi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vanda-announces-ema-positive-opinion-for-orphan-drug-designation-of-imsidolimab-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vanda-announces-ema-positive-opinion-for-orphan-drug-designation-of-imsidolimab-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4081","BK4139","EPV","VNDA","BBP","EMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120952118","title":"Attovia Therapeutics, a Biopharmaceutical Firm Focused on Immune-Mediated Diseases, Files for U.S. IPO Seeking $100 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1120952118","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120952118?lang=en_us&edition=fundamental","pubTime":"2026-07-15 10:54","pubTimestamp":1784084075,"startTime":"0","endTime":"0","summary":"Clinical-stage biopharmaceutical company Attovia Therapeutics has filed for an initial public offering with the goal of raising up to $100 million.The firm plans to list on the Nasdaq exchange under...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","IBBQ","MRNY","BBP","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651484502","title":"Regeneron’s dupilumab granted orphan drug designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2651484502","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651484502?lang=en_us&edition=fundamental","pubTime":"2026-07-15 05:05","pubTimestamp":1784063112,"startTime":"0","endTime":"0","summary":"Regeneron’s (REGN) dupilumab was granted FDA orphan drug designation, according to a post on the agency’s website. Published first on TheFly – the ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regenerons-dupilumab-granted-orphan-drug-designation-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regenerons-dupilumab-granted-orphan-drug-designation-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0823416689.USD","BBH","LU2106854487.HKD","LU1974910355.USD","LU2362541273.HKD","IBB","BK4585","LU2362540622.SGD","REGN","LU0823434740.USD","LU1917777945.USD","LU0889565916.HKD","LU2468319806.SGD","LU0114720955.EUR","BK4139","LU0823434583.USD","LU0053666078.USD","LABU","LU2237438978.USD","IBBQ","LU2023250504.SGD","LU0058720904.USD","BBP","BK4588","LU0320765992.SGD","LU2362541513.USD","LU2089984988.USD","LU0109394709.USD","LU0882574055.USD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651655484","title":"Celcuity announces FDA approval of Revtorpyk","url":"https://stock-news.laohu8.com/highlight/detail?id=2651655484","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651655484?lang=en_us&edition=fundamental","pubTime":"2026-07-15 04:55","pubTimestamp":1784062511,"startTime":"0","endTime":"0","summary":"Celcuity (CELC) announced that the U.S. Food and Drug Administration approved REVTORPYK for the treatment of patients with hormone receptor positiv...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/celcuity-announces-fda-approval-of-revtorpyk-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/celcuity-announces-fda-approval-of-revtorpyk-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","BK4588","IDNA","IBB","PINK","MRNX","BK4139","LFSC","FRTY","MRNY","IYH","GDOC","BK4585","LABU","PSCH","MEDI","SYNB","TECB","BBP","CELC","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651105407","title":"Caris Life Sciences expands prostate cancer offering with PTEN IHC testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2651105407","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651105407?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:35","pubTimestamp":1784032510,"startTime":"0","endTime":"0","summary":"Caris Life Sciences (CAI) will offer in-house PTEN immunohistochemistry, or IHC, testing following the recent FDA approval of a biomarker-guided th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-expands-prostate-cancer-offering-with-pten-ihc-testing-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-expands-prostate-cancer-offering-with-pten-ihc-testing-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IHC","LABU","MEDI","BK4104","IDNA","PTEN","MRNX","PINK","PSCH","RSPH","SYNB","LFSC","MRNY","BK4585","BMED","BK4588","BK4092","BK4162","CAI","BK4139","FRTY","GDOC","TECB","IBB","BBP","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651612476","title":"Nexalis Therapeutics Options Expire Unexercised, Streamlining Capital Structure","url":"https://stock-news.laohu8.com/highlight/detail?id=2651612476","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651612476?lang=en_us&edition=fundamental","pubTime":"2026-07-14 13:27","pubTimestamp":1784006857,"startTime":"0","endTime":"0","summary":"InhaleRx Limited ( ($AU:NX1) ) just unveiled an announcement. Nexalis Therapeutics Ltd, an ASX-listed biotechnology company trading under the ticke...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nexalis-therapeutics-options-expire-unexercised-streamlining-capital-structure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nexalis-therapeutics-options-expire-unexercised-streamlining-capital-structure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","BK4585","BK4588","IBB","SYNB","BK4539","LENZ","AGNG","DARP","FWD","XT","BBP","BK4007","BK4139","FHLC","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651247371","title":"Nexalis Therapeutics Issues Over 4.1 Million Unquoted Performance Rights","url":"https://stock-news.laohu8.com/highlight/detail?id=2651247371","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651247371?lang=en_us&edition=fundamental","pubTime":"2026-07-14 13:27","pubTimestamp":1784006835,"startTime":"0","endTime":"0","summary":"InhaleRx Limited ( ($AU:NX1) ) just unveiled an update. Nexalis Therapeutics Ltd is an Australian-listed biotechnology company focused on developin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nexalis-therapeutics-issues-over-4-1-million-unquoted-performance-rights?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nexalis-therapeutics-issues-over-4-1-million-unquoted-performance-rights?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BBP","IBB","LENZ","RSPH","SYNB","BK4139","XT","BK4007","BK4585","FHLC","DARP","FWD","BK4539","AGNG","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651422771","title":"BioArctic’s Partner Eisai Wins FDA Nod for At-Home Leqembi Injection in Early Alzheimer’s","url":"https://stock-news.laohu8.com/highlight/detail?id=2651422771","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651422771?lang=en_us&edition=fundamental","pubTime":"2026-07-14 06:08","pubTimestamp":1783980525,"startTime":"0","endTime":"0","summary":"BioArctic AB Class B ( ($SE:BIOA.B) ) has shared an update. BioArctic’s partner Eisai has secured U.S. FDA approval for Leqembi Iqlik, a once-weekl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bioarctics-partner-eisai-wins-fda-nod-for-at-home-leqembi-injection-in-early-alzheimers?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bioarctics-partner-eisai-wins-fda-nod-for-at-home-leqembi-injection-in-early-alzheimers?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999002679.SGD","MRNX","IBB","SG9999014484.SGD","LU0251143029.SGD","IYH","LU2152927971.USD","HBCP","SE","RSPH","SG9999014492.USD","GDOC","LABU","LU1861220207.SGD","BK4554","SG9999002620.SGD","BK4535","LU0823039010.USD","LFSC","LU2360107671.USD","LU2125910849.SGD","PINK","LU0499858438.USD","LU0516423091.SGD","LU0532188223.SGD","BBP","BMED","IE0031814969.USD","FDNI","FRTY","LU2065170008.USD","BK4585","LU0441851309.USD","BK4220","LU0516423174.USD","BK4588","PSCH","SG9999002414.USD","SG9999013478.USD","BK4503","TECB","SG9999002406.SGD","SYNB","LU0589944569.HKD","MEDI","BK4211","LU2065171402.SGD","MRNY","LU0516422366.SGD","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651144496","title":"Lakefront Biotherapeutics Board Member Resigns After Sanofi R&D Appointment","url":"https://stock-news.laohu8.com/highlight/detail?id=2651144496","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651144496?lang=en_us&edition=fundamental","pubTime":"2026-07-14 04:57","pubTimestamp":1783976270,"startTime":"0","endTime":"0","summary":"Lakefront Biotherapeutics ( ($LKFT) ) has provided an update. Lakefront Biotherapeutics, a Belgium-based biotechnology company listed on Euronext a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lakefront-biotherapeutics-board-member-resigns-after-sanofi-rd-appointment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lakefront-biotherapeutics-board-member-resigns-after-sanofi-rd-appointment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","BK4007","SNYNF","RSPH","DARP","SYNB","BK4585","BK4588","FHLC","BBP","XT","JDOC","AGNG","FWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651019180","title":"Actinogen Medical Announces Employee Share Scheme Buy-Back","url":"https://stock-news.laohu8.com/highlight/detail?id=2651019180","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651019180?lang=en_us&edition=fundamental","pubTime":"2026-07-13 15:38","pubTimestamp":1783928315,"startTime":"0","endTime":"0","summary":"Actinogen Medical ( ($AU:ACW) ) has provided an announcement. Actinogen Medical Ltd., an ASX-listed biotechnology company trading under the ticker ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-announces-employee-share-scheme-buy-back-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-announces-employee-share-scheme-buy-back-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","DARP","SYNB","BK4585","AGNG","FWD","XT","IBB","BBP","JDOC","BK4588","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651196208","title":"Island Pharmaceuticals Issues Unquoted Options Under Employee Incentive Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2651196208","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651196208?lang=en_us&edition=fundamental","pubTime":"2026-07-13 14:33","pubTimestamp":1783924409,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals Ltd ( ($AU:ILA) ) has provided an announcement. Island Pharmaceuticals Ltd is an Australian-listed biotechnology company foc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/island-pharmaceuticals-issues-unquoted-options-under-employee-incentive-scheme?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/island-pharmaceuticals-issues-unquoted-options-under-employee-incentive-scheme?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BBP","FHLC","FWD","DARP","AGNG","RSPH","IBB","SYNB","JDOC","BK4585","XT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156997423","title":"Insilico Medicine Surges Over 7% in Morning Trading on New AI Drug Discovery Partnership with CMS","url":"https://stock-news.laohu8.com/highlight/detail?id=1156997423","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156997423?lang=en_us&edition=fundamental","pubTime":"2026-07-13 10:10","pubTimestamp":1783908642,"startTime":"0","endTime":"0","summary":"Insilico Medicine (03696) shares rose more than 7% in early trading. At the time of writing, the stock is up 6.21% to HK$45.48, with a turnover of HK$332 million. On July 13th, according to a post on...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIPO","IE00BYV24P56.USD","00867","CHAT","BK1191","VTHR","IBB","SG9999015978.USD","IE00BVYPNQ40.USD","SG9999015986.USD","ARTY","IE00BGHQDM52.EUR","LFSC","SBIO","BK4585","SG9999004220.SGD","BK4588","GDOC","BK1593","PBE","SG9999015945.SGD","WRND","QTOC","AGIX","IE00BMCWC346.EUR","GSKH","IE00BVYPNP33.GBP","SG9999015952.SGD","LU2488822045.USD","BBP"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":8,"totalSize":179,"code":"91000000","status":"200"}]}}